DXCM News and Press, DexCom Inc. From 04/15/24

2024-04-15 02:54:24 ET Summary I created two dummy portfolios for a giant tortoise and a cat to provide context for my articles. The first quarter of the year is ending, prompting a swift evaluation of the evolution, results, metrics, critique style, and unresolved points of these...

2024-04-11 09:02:57 ET Summary DexCom received FDA approval for its continuous glucose monitoring product, Stelo, to be available over the counter, making it the first OTC CGM product ever. The company has demonstrated robust growth in revenue and operating income, warranting its ...

2024-04-08 08:30:00 ET Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight. However, long-term investors know that one quarterly report rarely c...

2024-04-05 10:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will hold a conference call to review the company's first quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the ...

2024-04-01 03:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-29 09:59:07 ET Summary The diabetes and obesity markets are large and growing, with an estimated total long-term addressable market of $100 billion in the US alone. Denmark's Novo Nordisk and US-based Eli Lilly are leading pharmaceutical companies in the development of GLP...

2024-03-25 14:04:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors got a good case of whiplash over the past four years. The pandemic crash of 2020 brought a decade-long bull market to a screeching halt. However, the spin-up into the revenge-buying b...

2024-03-14 12:44:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That’s according to Emergen Research. By 2034, it could hit $8...

2024-03-12 13:00:03 ET Shagun Singh from RBC Capital issued a price target of $165.00 for DXCM on 2024-03-12 11:54:00. The adjusted price target was set to $165.00. At the time of the announcement, DXCM was trading at $134.475. The overall price target consensus is at $7...